Annals of Oncology · 2019 · 32 citations · 0 references
MedicineImmunologyOncologyBreast OncologyImmunotherapyMetastasisBreast Cancer OncologyCancer ImmunotherapyImmune Checkpoint InhibitorsImmuno-oncology BiomarkersMetastatic Breast CancerTumor AntigensPd-l1 BlockadeProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 BiomarkerProgrammed Death-ligand 1 InhibitionProgrammed Death-ligand 1 TargetingTnm Staging SystemTriple-negative Breast Cancer TherapyTumor Marker Assay Development